Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
LTR Pharma Limited ( (AU:LTP) ) has shared an announcement.
LTR Pharma Limited has released its half-year report for the period ending December 31, 2024, in compliance with ASX listing requirements. The report includes the consolidated financial report and the Directors’ Report, providing stakeholders with insights into the company’s financial performance during this period.
More about LTR Pharma Limited
YTD Price Performance: -22.22%
Average Trading Volume: 649,717
Technical Sentiment Consensus Rating: Strong Buy
Find detailed analytics on LTP stock on TipRanks’ Stock Analysis page.